Skip to NavigationSkip to content

News

Alex Azar is officially President Trump’s nominee for the position as head of the Health and Human Services agency, in a decision that was already...
US drug maker Mylan has announced its intention to withdraw from the Tel Aviv Stock Exchange (TASE), ending its involvement for the first time...
Novartis posted strong results for its wet age-related macular degeneration drug, by showing superiority against Eylea in Phase 3 trials. The data...
Roche's Ocrevus received a positive recommendation from the Committee for Medical Products for Human Use (CHMP) in the treatment of active...
A recent report by the OECD shares concerns that the UK’s overall health looks set to face a crisis due to the rising levels of obesity that the...
Nigeria’s drug regulatory body has fiercely countered claims made by Chief Economist of PwC in West Africa, Andrew Nevin, that 70% of the drugs...
GSK appoints Roche veteran as Head of R&D leaves for UK Government role, while it emerges that 17,000 English patients are surviving with Stage 4...
Dynavax had said it was the last throw of the dice for its hepatitis B vaccine, Hepislav-B, after it was first rejected in 2013 and then later in...
Sanofi has decided to build its pipeline in neurological disorders with the agreement to develop Principia Biopharma’s BTK inhibitor candidate for...
New findings from the Early Breast Cancer Trialists' Collaborative Group have demonstrated that oestrogen receptor-positive breast cancer is able to...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches